Specific KIR-HLA genotypes predict outcomes in refractory or relapsed primary central nervous system lymphoma.
Hematology
; 28(1): 2243424, 2023 Dec.
Article
in En
| MEDLINE
| ID: mdl-37545411
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lymphoma, Non-Hodgkin
/
Central Nervous System Neoplasms
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Humans
/
Middle aged
Language:
En
Journal:
Hematology
Journal subject:
HEMATOLOGIA
Year:
2023
Document type:
Article
Country of publication:
United kingdom